Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · Real-Time Price · USD

Compare

10.04

+1.58 (18.68%)

At close: Oct 10, 2025, 4:00 PM EDT

9.82

-0.22 (-2.19%)

After-hours: Oct 10, 2025, 7:59 PM EDT

Monte Rosa Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	24.17	-72.7	-135.35	-108.5	-73.96	-35.88
Depreciation & Amortization	8.34	8.12	6.22	3.75	2.13	0.54
Stock-Based Compensation	18.94	18.13	16.67	11.66	5.2	0.35
Other Adjustments	-3.55	-2.95	-3.81	2.76	0.98	7.68
Change in Receivables	-1.53	0.33	1.9	-0.19	-0.7	-
Changes in Accounts Payable	-1.05	6.25	5.76	-0.74	6.59	3.44
Changes in Accrued Expenses	0.95	4.18	3.56	1.03	1.11	1.13
Changes in Unearned Revenue	-26.77	83.38	50	-	-	-
Changes in Other Operating Activities	-0.72	-2.75	11.25	-2.23	-0.71	-0.31
Operating Cash Flow	27.72	42	-43.8	-92.47	-59.36	-23.05
Capital Expenditures	-3.86	-3.99	-19.04	-12.91	-9.73	-3.39
Sale of Property, Plant & Equipment	-	-	0.06	0.11	0.08	-
Purchases of Investments	-257.38	-230.36	-103.15	-384.42	-	-
Proceeds from Sale of Investments	193.19	189.9	210.93	178	-	-
Investing Cash Flow	-68.05	-44.45	88.8	-219.22	-9.65	-3.39
Issuance of Common Stock	-	99.53	27.61	20.83	237.9	-
Net Common Stock Issued (Repurchased)	-	99.53	27.61	20.83	237.9	-
Issuance of Preferred Stock	-	-	-	-	143	60.5
Net Preferred Stock Issued (Repurchased)	-	-	-	-	143	60.5
Other Financing Activities	-	-0.64	-0.12	-0.36	-3.34	-0.44
Financing Cash Flow	1	98.89	27.49	20.47	377.56	60.06
Net Cash Flow	-39.33	96.44	72.49	-291.22	308.55	33.62
Beginning Cash & Cash Equivalents	113.71	132.68	60.19	351.41	42.86	9.25
Ending Cash & Cash Equivalents	74.38	229.12	132.68	60.19	351.41	42.86
Free Cash Flow	23.85	38.01	-62.84	-105.38	-69.1	-26.44
Free Cash Flow Growth	-37.24%	-	-	-	-	-
FCF Margin	13.40%	50.26%	-	-	-	-
Free Cash Flow Per Share	0.29	0.51	-1.22	-2.23	-2.76	-17.43
Levered Free Cash Flow	1.05	22.5	-77.6	-119.61	-74.57	-34.48
Unlevered Free Cash Flow	-5.92	17.06	-85.2	-123.5	-73.49	-26.61

Updated Aug 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q